Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.
about
Analysis of antibody responses to protective antigen-based anthrax vaccines through use of competitive assaysInduction of neutralizing antibody responses to anthrax protective antigen by using influenza virus vectors: implications for disparate immune system priming pathwaysNeutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigenAnthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine.CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies.Regulation of anthrax toxin-specific antibody titers by natural killer T cell-derived IL-4 and IFNγ.New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.Mucosal priming of newborn mice with S. Typhi Ty21a expressing anthrax protective antigen (PA) followed by parenteral PA-boost induces B and T cell-mediated immunity that protects against infection bypassing maternal antibodiesA requirement for FcγR in antibody-mediated bacterial toxin neutralization.Immunization of Mice with Anthrax Protective Antigen Limits Cardiotoxicity but Not Hepatotoxicity Following Lethal Toxin ChallengeMHC class II and non-MHC class II genes differentially influence humoral immunity to Bacillus anthracis lethal factor and protective antigen.Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthraxStochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralizationSynthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen.Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies.Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis.Recombinant Sindbis virus vectors designed to express protective antigen of Bacillus anthracis protect animals from anthrax and display synergy with ciprofloxacin.A human/murine chimeric fab antibody neutralizes anthrax lethal toxin in vitro.B. anthracis in a wool-processing factory: seroprevalence and occupational risk.Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability.Development and application of a Bacillus anthracis protective antigen domain-1 in-house ELISA for the detection of anti-protective antigen antibodies in cattle in Zambia
P2860
Q28383562-0B433193-FDD6-4845-970B-C52BE17ABF0FQ28397551-B0509303-3B55-4BAB-972B-2E15EF57FE96Q33496407-D150F206-6769-42F6-96D9-257EFD3BEF56Q33505445-279158AD-DE02-431B-9E0B-832EC133CB43Q33769076-D49F48C4-FE0C-4CC1-9ED5-0A5539B6154AQ34000070-BD69BA45-317D-4252-96CC-A2106ECA5475Q34066161-53EE1274-3D1C-4880-9FA1-64C01A2B3626Q34121874-4D87BC07-EB87-4A64-B3CB-3D95DDEEB8E1Q34243378-8E02D2AF-A286-4CDF-B6D0-F2FF09761A1BQ35894690-A7AFA8E9-8783-40FF-9882-0B3308A050BAQ36482706-0A084E9A-FD25-4269-A54A-2FD64959C5D0Q36668524-1C0A2641-5CF3-4D88-A88E-BF5B72F452A3Q36733960-70AE1725-B0D8-4008-94CA-028EC2B8F80FQ37274918-A39BC77A-A461-4DA4-90CA-5A9D236A5F68Q37375729-17252EBF-CB6F-4CED-963B-115A6F7EF990Q37404847-9E1F9331-24DF-4BA2-8126-78E9AA97985EQ37410033-A75FEBF7-BEB6-43A4-B65A-9224637CE952Q39124815-D0535B23-4C7A-486A-9E2C-052C9CE1ED3AQ44846063-C5D70FFA-DB20-4110-BC43-B069D223FE13Q49387341-316EA047-517B-45FA-86B6-C91604A5AF33Q58601539-1A1B8FBA-210A-4075-BD9F-CC6EC9E83CB5
P2860
Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Immunogenicity of Bacillus ant ...... nd on host genetic background.
@ast
Immunogenicity of Bacillus ant ...... nd on host genetic background.
@en
Immunogenicity of Bacillus ant ...... nd on host genetic background.
@nl
type
label
Immunogenicity of Bacillus ant ...... nd on host genetic background.
@ast
Immunogenicity of Bacillus ant ...... nd on host genetic background.
@en
Immunogenicity of Bacillus ant ...... nd on host genetic background.
@nl
prefLabel
Immunogenicity of Bacillus ant ...... nd on host genetic background.
@ast
Immunogenicity of Bacillus ant ...... nd on host genetic background.
@en
Immunogenicity of Bacillus ant ...... nd on host genetic background.
@nl
P2860
P356
P1476
Immunogenicity of Bacillus ant ...... nd on host genetic background.
@en
P2093
Nareen Abboud
P2860
P304
P356
10.1128/CVI.00015-08
P577
2008-05-14T00:00:00Z